Sebastian Bunk, Ph.D.

Senior Director

TCR Engineering & Bispecifics

Sebastian Bunk joined Immatics in 2014 where he is responsible for developing a pipeline of bispecific T cell-engaging receptor (TCER™) molecules. His department is dedicated to generating preclinical proof-of-concept for efficacy, safety and manufacturability of novel TCER™ programs. He has further responsibility in structure-based optimization of T cell receptors (TCRs) for improving their performance in adoptive cell therapy (ACT).

Under Sebastian’s scientific leadership, Immatics established innovative technology for affinity maturation of TCRs and generation of bispecific TCER™ molecules. He is an inventor on 10+ patents related to discovery and engineering of TCRs and bispecific TCER™ programs and has co-authored 10+ publications in peer-reviewed journals.

Sebastian obtained his Ph.D. in Biochemical Pharmacology from the University of Konstanz. Prior to joining Immatics, he worked as Manager at Baxter Innovations in Vienna where he led R&D projects related to different biotherapeutics, such as intravenous immunoglobulin.


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.